Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells - PubMed (original) (raw)

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells

A C Eaves et al. Proc Natl Acad Sci U S A. 1986 Jul.

Erratum in

Proc Natl Acad Sci U S A 1987 Feb;84(4):1117

Abstract

Previous studies have shown that Philadelphia (Ph1) chromosome-positive chronic myeloid leukemia (CML) results from the abnormal expansion at the pluripotent stem cell level of a single clone of hemopoietic cells. Although it seems likely that this is related to the heightened proliferative activity characteristic of primitive CML progenitor cell types, the underlying mechanism is unknown. In this report we show that either normal or CML peripheral blood progenitors can be maintained on preestablished normal marrow adherent layers for periods of 1-2 months. Under these conditions numbers of both normal and neoplastic progenitors are usually higher in the adherent layer than in the nonadherent fraction. Moreover, the number of primitive progenitors of high proliferative potential present in the adherent layer is sufficient to allow their cycling status to be determined. Such measurements demonstrate that primitive normal progenitors of blood origin, when cultured in the presence of a preestablished adherent marrow feeder layer, go in and out of cycle after each medium change but in the absence of a feeder layer remain continuously in cycle. In contrast, primitive CML progenitors of either blood or marrow origin cycle continuously regardless of the presence or absence of an adherent feeder layer. We suggest that early expansion of the CML clone is related to an ability of the neoplastic stem cells to ignore or overcome a negative regulatory signal produced by nonneoplastic adherent marrow cells whose normal function is to maintain the stem cell reserve in a quiescent state.

PubMed Disclaimer

Cited by

Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.
Hurley RW, McCarthy JB, Verfaillie CM. Hurley RW, et al. J Clin Invest. 1995 Jul;96(1):511-9. doi: 10.1172/JCI118063. J Clin Invest. 1995. PMID: 7542285 Free PMC article.
Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway.
Beaulieu A, Poncin G, Belaid-Choucair Z, Humblet C, Bogdanovic G, Lognay G, Boniver J, Defresne MP. Beaulieu A, et al. PLoS One. 2011;6(10):e25651. doi: 10.1371/journal.pone.0025651. Epub 2011 Oct 3. PLoS One. 2011. PMID: 21991326 Free PMC article.
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
McWhirter JR, Wang JY. McWhirter JR, et al. Mol Cell Biol. 1991 Mar;11(3):1553-65. doi: 10.1128/mcb.11.3.1553-1565.1991. Mol Cell Biol. 1991. PMID: 1705008 Free PMC article.
The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.
Renshaw MW, McWhirter JR, Wang JY. Renshaw MW, et al. Mol Cell Biol. 1995 Mar;15(3):1286-93. doi: 10.1128/MCB.15.3.1286. Mol Cell Biol. 1995. PMID: 7862122 Free PMC article.
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.
Chomel JC, Turhan AG. Chomel JC, et al. Oncotarget. 2011 Sep;2(9):713-27. doi: 10.18632/oncotarget.333. Oncotarget. 2011. PMID: 21946665 Free PMC article.

References

1. Exp Hematol. 1981 Sep;9(8):871-7 - PubMed
1. Blood. 1980 Jun;55(6):931-6 - PubMed
1. J Cell Physiol Suppl. 1982;1:37-43 - PubMed
1. J Cell Physiol Suppl. 1982;1:79-85 - PubMed
1. Br J Haematol. 1982 May;51(1):131-46 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells - PubMed (original) (raw)